GB8901778D0 - Manipulatory technique - Google Patents

Manipulatory technique

Info

Publication number
GB8901778D0
GB8901778D0 GB898901778A GB8901778A GB8901778D0 GB 8901778 D0 GB8901778 D0 GB 8901778D0 GB 898901778 A GB898901778 A GB 898901778A GB 8901778 A GB8901778 A GB 8901778A GB 8901778 D0 GB8901778 D0 GB 8901778D0
Authority
GB
United Kingdom
Prior art keywords
manipulatory
technique
manipulatory technique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898901778A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
University of Glasgow
Original Assignee
University of Edinburgh
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh, University of Glasgow filed Critical University of Edinburgh
Priority to GB898901778A priority Critical patent/GB8901778D0/en
Publication of GB8901778D0 publication Critical patent/GB8901778D0/en
Priority to GB9001808A priority patent/GB2228487B/en
Priority to JP50267690A priority patent/JPH04503004A/en
Priority to AU50276/90A priority patent/AU633052B2/en
Priority to EP19900902361 priority patent/EP0455695A1/en
Priority to PCT/GB1990/000116 priority patent/WO1990008832A1/en
Priority to CA 2045480 priority patent/CA2045480A1/en
Priority to NZ23227490A priority patent/NZ232274A/en
Priority to FI913582A priority patent/FI913582A0/en
Pending legal-status Critical Current

Links

GB898901778A 1989-01-27 1989-01-27 Manipulatory technique Pending GB8901778D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB898901778A GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique
GB9001808A GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
JP50267690A JPH04503004A (en) 1989-01-27 1990-01-26 Retroviral vectors and their use in the production of transgenic animals
AU50276/90A AU633052B2 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
EP19900902361 EP0455695A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
PCT/GB1990/000116 WO1990008832A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
CA 2045480 CA2045480A1 (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals
NZ23227490A NZ232274A (en) 1989-01-27 1990-01-29 Retroviral vector comprising the env gene product of feline leukemia virus-b (felv-b) and the gag and pol products of a retrovirus, transgenic sheep and pigs and a method of introducing nucleic acid into an animal embryo
FI913582A FI913582A0 (en) 1989-01-27 1991-07-26 RETROVIRAL VECTOR OCH DESS ANVAENDNING VID MODUCLERING AV TRANSGENA DJUR.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898901778A GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique

Publications (1)

Publication Number Publication Date
GB8901778D0 true GB8901778D0 (en) 1989-03-15

Family

ID=10650690

Family Applications (2)

Application Number Title Priority Date Filing Date
GB898901778A Pending GB8901778D0 (en) 1989-01-27 1989-01-27 Manipulatory technique
GB9001808A Expired - Lifetime GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9001808A Expired - Lifetime GB2228487B (en) 1989-01-27 1990-01-26 Retroviral vector and its use in the production of transgenic animals

Country Status (8)

Country Link
EP (1) EP0455695A1 (en)
JP (1) JPH04503004A (en)
AU (1) AU633052B2 (en)
CA (1) CA2045480A1 (en)
FI (1) FI913582A0 (en)
GB (2) GB8901778D0 (en)
NZ (1) NZ232274A (en)
WO (1) WO1990008832A1 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138553C1 (en) * 1991-09-30 1999-09-27 Берингер Ингельгейм Интернациональ ГмбХ Transfection composition for higher eucaryotic cells, nucleic acid complex useful as component of transfection composition, conjugate useful as component of transfection composition, endosomolytic peptide useful as component of transfection composition
WO1993024626A1 (en) * 1992-05-28 1993-12-09 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
GB2269175A (en) * 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP0662139A1 (en) * 1992-09-21 1995-07-12 Chiron Corporation Recombinant retroviral vector against felv and/or fiv
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US6066778A (en) * 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
US6080910A (en) * 1997-02-20 2000-06-27 Case Western Reserve University Transgenic knockout animals lacking IgG3
JP2001514663A (en) 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． Methods for treating or preventing Alzheimer's disease
US6080912A (en) * 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
US6080911A (en) * 1997-04-15 2000-06-27 Ohio University Mice models of growth hormone insensitivity
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6060310A (en) * 1997-11-24 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Transcription factor decoy and tumor growth inhibitor
US6500637B1 (en) 1998-03-31 2002-12-31 The Institute Of Physical And Chemical Research Neurogenesis inducing genes
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
EP1130960A4 (en) * 1998-11-19 2003-07-30 Wisconsin Alumni Res Found TRANSGENIC ANIMALS
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US6759525B2 (en) 2000-08-25 2004-07-06 The United States Of America As Represented By The Department Of Health And Human Services Protein kinase A and carney complex
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
US6849449B2 (en) 2001-03-01 2005-02-01 Regents Of The University Of Michigan Orphanin FQ receptor nucleic acids
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
JP3966819B2 (en) 2001-05-24 2007-08-29 キム，スーギョン Novel second keratinocyte growth factor analogue present in the hair follicle
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
WO2003022040A2 (en) 2001-09-13 2003-03-20 California Institute Of Technology Method for producing transgenic animals
US7582425B2 (en) 2001-09-21 2009-09-01 The Regents Of The University Of Michigan Atlastin
US7108975B2 (en) 2001-09-21 2006-09-19 Regents Of The University Of Michigan Atlastin
EP1953244A1 (en) 2002-01-09 2008-08-06 Nakamura, Yusuke Cancer profiles
US7255986B2 (en) 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
EP1545595B1 (en) 2002-08-30 2010-07-07 Biorexis Pharmaceutical Corporation Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
US7173010B2 (en) 2003-05-19 2007-02-06 Regents Of The University Of Michigan Orphanin FQ receptor
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7432057B2 (en) 2004-01-30 2008-10-07 Michigan State University Genetic test for PSE-susceptible turkeys
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
WO2006002161A2 (en) 2004-06-18 2006-01-05 Duke University Modulators of odorant receptors
CA2608348A1 (en) 2005-05-12 2006-11-23 Third Wave Technologies, Inc. Polymorphic ghsr nucleic acids and uses thereof
WO2006138275A2 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
TW200732347A (en) 2005-10-06 2007-09-01 Trophogen Inc VEGF analogs and methods of use
US7794951B2 (en) 2005-10-18 2010-09-14 University Of Massachusetts Medical School SREBP2gc transcription factors and uses thereof
DK2481756T3 (en) 2005-10-31 2017-10-09 Oncomed Pharm Inc Compositions and Methods for Diagnosing and Treating Cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
US9277737B2 (en) 2006-09-21 2016-03-08 Probiodrug Ag Mouse models carrying a knock-out mutation of the QPCTL-gene
DK2121944T3 (en) 2007-01-19 2011-10-31 Probiodrug Ag In vivo screening models for the treatment of Alzheimer's disease and other QPCT-related disorders
EP2106439B1 (en) 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
WO2009005809A2 (en) 2007-07-02 2009-01-08 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
EP2604701B1 (en) 2007-07-06 2015-11-04 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
WO2009009431A2 (en) 2007-07-06 2009-01-15 The Regents Of The University Of Michigan Mipol1-etv1 gene rearrangements
EP2179292B1 (en) 2007-08-16 2012-11-28 The Regents of the University of Michigan Metabolomic profiling of prostate cancer
JP2011501652A (en) 2007-09-12 2011-01-13 プロビオドルグ エージー Transgenic mouse
US9462793B2 (en) 2008-01-14 2016-10-11 Probiodrug Ag Mouse carrying a knock-out mutation of the Qpct-gene
US8592643B2 (en) 2008-01-29 2013-11-26 Central Institute For Experimental Animals Methods for introducing a human gene into a marmoset embryo for making a transgenic marmoset
ES2663536T3 (en) 2008-09-26 2018-04-13 Oncomed Pharmaceuticals, Inc. Agents that bind to frizzled receptors and uses thereof
AU2010203517B2 (en) 2009-01-09 2012-08-16 The Regents Of The University Of Michigan Recurrent gene fusions in cancer
TWI535445B (en) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt antagonists and methods of treatment and screening
EP3450979A3 (en) 2010-03-17 2019-04-24 The Regents of The University of Michigan Using phage epitopes to profile the immune response
NZ602700A (en) 2010-04-01 2014-10-31 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
JP2013541938A (en) 2010-09-02 2013-11-21 プロビオドルグ エージー In vivo screening model for the treatment of isoQC related disorders
WO2012135549A2 (en) 2011-03-29 2012-10-04 Dynavax Technologies Corporation Tlr8 transgenic animals
EP2742062A2 (en) 2011-08-12 2014-06-18 Probiodrug AG In vivo screening models for treatment of qc-related disorders
WO2013053765A1 (en) 2011-10-11 2013-04-18 Proyecto De Biomedicina Cima, S.L. A non-human animal model of mucosa-associated lymphoid tissue (malt) lymphoma
AU2013257161B2 (en) 2012-05-02 2017-11-09 New York University Methods of treating and preventing Staphylococcus aureus infections and associated conditions
EP3533874A1 (en) 2012-07-30 2019-09-04 Trophogen Inc. Glycoprotein hormone long-acting superagonists
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
US9266959B2 (en) 2012-10-23 2016-02-23 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using frizzled-binding agents
JP2016510411A (en) 2013-02-04 2016-04-07 オンコメッド ファーマシューティカルズ インコーポレイテッド Methods and monitoring of treatment with WNT pathway inhibitors
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP3610724A1 (en) 2013-09-12 2020-02-19 Icahn School of Medicine at Mount Sinai T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated t cells, and methods of use
MX2016005973A (en) 2013-11-05 2016-11-14 Trophogen Inc Glycoprotein hormone long-acting superagonists.
DE102016221219A1 (en) 2016-10-27 2018-05-03 Schaeffler Technologies AG & Co. KG Method and plant for producing a friction lining made of sintered metal
JP2023533857A (en) 2020-07-17 2023-08-04 ヤンセン バイオテツク，インコーポレーテツド Anti-idiotypic antibody against anti-KLK2 antibody
US20240374761A1 (en) 2021-05-05 2024-11-14 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2022259190A1 (en) 2021-06-10 2022-12-15 Janssen Biotech, Inc. Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252940A4 (en) * 1985-12-05 1989-07-27 Hutchinson Fred Cancer Res ANTI-DETECTION RNA FOR THE TREATMENT OF RETROVIRAL DISEASES.
WO1989011539A1 (en) * 1988-05-17 1989-11-30 Sloan-Kettering Institute For Cancer Research Retroviral vector
ES2084596T3 (en) * 1988-12-13 1996-05-16 Harvard College FELV ISOLATED MATERIALS PROTOTYPES FOR USE IN DISEASE AND VACCINE MODELS.

Also Published As

Publication number Publication date
JPH04503004A (en) 1992-06-04
AU5027690A (en) 1990-08-24
FI913582A0 (en) 1991-07-26
WO1990008832A1 (en) 1990-08-09
EP0455695A1 (en) 1991-11-13
GB2228487A (en) 1990-08-29
CA2045480A1 (en) 1990-07-28
AU633052B2 (en) 1993-01-21
GB9001808D0 (en) 1990-03-28
GB2228487B (en) 1992-09-09
NZ232274A (en) 1992-09-25

Similar Documents

Publication Publication Date Title
GB8901778D0 (en) Manipulatory technique
DE4090310D2 (en) Teleskopkrone
AU108277S (en) Hedge-shears
CS9005442A2 (en) Symmetrizer
CS490790A3 (en) Chaff-cutter
DE4092115D2 (en) Sanitaere mischbatterie
DE4090110D2 (en) Rotationskolbenverbrennungskraftmaschine
DE4091364D2 (en) Thermosaeulen-strahlungsdetektor
DE4091275D2 (en) Steppdecke
GB9005159D0 (en) Container-loading devices
BG49771A1 (en) Electric- bow evaparator
GB2236998B (en) Non-refill devices
DE4090235D2 (en) Hauptabsperrventil
DE4090763D2 (en) Abfallsammler
DE4091102D2 (en) Spundlochverschluss
DE3991687D2 (en) Dufttresor
DE3991686D2 (en) Schmuckblende
GB8923698D0 (en) Non-refilling devices
CA64463S (en) Tapeplayer
CA64817S (en) Liminaire
CA64838S (en) Automibile
DE3991146D2 (en) Schraubverschluss
IE890646L (en) Solid eledtrolyte devices
GB8929037D0 (en) Devices
GB8920751D0 (en) Devices